Skip to content SHCC MU-NCORP

Research

ACCOMPLISHMENTS AND CONTRIBUTIONS

The SHCC Minority/Underserved National Cancer Institute Community Oncology Research Program (MU-NCORP), with its novel ancillary programs and dedicated and tireless staff, is an excellent cancer program with national recognition. The program is holistic in approach, and more than 1470 patients have participated in NCI-approved clinical oncology trials. Our accomplishments and contributions are partly summarized in the lists below:

PROTOCOL DEVELOPMENT: 2017

E1Q11 EROS trial from its inception back in 2012 and preactivation in 2014 has progressed tremendously. At this day it is a fully accruing trial with nearly 100 patients accrued!

For more information about the E1Q11 EROS trial please check: ecog-acrin.org and clinicaltrials.gov.